Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma

NCT00678327 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1202

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: bleomycin sulfate
BIOLOGICAL: filgrastim
BIOLOGICAL: pegfilgrastim
DRUG: cyclophosphamide
DRUG: dacarbazine
DRUG: doxorubicin hydrochloride
DRUG: etoposide
DRUG: prednisolone
DRUG: procarbazine hydrochloride
DRUG: vinblastine sulfate
DRUG: vincristine sulfate

Sponsor

University College, London

Collaborators

[object Object]
[object Object]